RxDoctor Payments DataLook up a doctor →

Nausheen Ahmed, MD

Hematology · Westwood, KSNPI 1750519856

Payments from drug & device makers

$1,034,896in general payments, 2019–2025

Across 227 payments — averaging $4559.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$807K
  • Genmab U.S., Inc.$104K
  • Pfizer$63K
  • Bristol Myers Squibb$26K
  • ADC Therapeutics America, Inc.$12K
  • E.r. Squibb & Sons, L.L.C.$10K
  • plus $13K from 16 others

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few hematology providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$133,699
Medicare patients
249
Services billed
1,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Westwood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →